BREAKING: SCOTUS says IPRs should be reviewable in Arthrex; hands more power to USPTO director
21-06-2021
Steve Heap / Shutterstock.com
In a decision highly anticipated by patent owners, the US Supreme Court has delivered its final ruling in US v Arthrex—a fractured opinion that lawyers say leaves burning questions around its political implications.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
Arthrex, patents, SCOTUS, PTAB, Finnegan, Haynes anD, Boone, Holwell Shuster & Goldberg, Axinn
